These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11207490

  • 1. A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section.
    Acharya G, Al-Sammarai MT, Patel N, Al-Habib A, Kiserud T.
    Acta Obstet Gynecol Scand; 2001 Mar; 80(3):245-50. PubMed ID: 11207490
    [Abstract] [Full Text] [Related]

  • 2. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon.
    Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, Refaey HE, Rodeck CH.
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):411-4. PubMed ID: 11787915
    [Abstract] [Full Text] [Related]

  • 3. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
    Owonikoko KM, Arowojolu AO, Okunlola MA.
    J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
    [Abstract] [Full Text] [Related]

  • 4. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N, Mittal S, Kumar S.
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [Abstract] [Full Text] [Related]

  • 5. The effect of intrauterine misoprostol on blood loss during caesarean section.
    Bahadur A, Khoiwal K, Bhattacharya N, Chaturvedi J, Kumari R.
    J Obstet Gynaecol; 2019 Aug; 39(6):753-756. PubMed ID: 31010345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
    Chaudhuri P, Banerjee GB, Mandal A.
    Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
    Alalfy M, Lasheen Y, Elshenoufy H, Elzahaby IM, Kaleem HW, El Sawah H, Azkalani A, Saber W, Rashwan ASSA.
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rectal vs. sublingual misoprostol before cesarean section: double-blind, three-arm, randomized clinical trial.
    Sweed MS, El-Saied MM, Abou-Gamrah AE, El-Sabaa HA, Abdel-Hamid MM, Hemeda H, Mansour AM, Shawky ME, El-Sayed MA, Mohamed RM.
    Arch Gynecol Obstet; 2018 Dec; 298(6):1115-1122. PubMed ID: 30291483
    [Abstract] [Full Text] [Related]

  • 13. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
    Othman ER, Fayez MF, El Aal DE, El-Dine Mohamed HS, Abbas AM, Ali MK.
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
    [Abstract] [Full Text] [Related]

  • 14. Sublingual misoprostol is as effective as intravenous oxytocin to reduce intra-operative blood loss during cesarean delivery in women living at high altitude.
    Gavilanes P, Morales MF, Velasco S, Teran E.
    J Matern Fetal Neonatal Med; 2016 Dec; 29(4):559-61. PubMed ID: 25666740
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery.
    Lapaire O, Schneider MC, Stotz M, Surbek DV, Holzgreve W, Hoesli IM.
    Int J Gynaecol Obstet; 2006 Oct; 95(1):2-7. PubMed ID: 16934269
    [Abstract] [Full Text] [Related]

  • 17. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [Abstract] [Full Text] [Related]

  • 18. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial.
    Chang FW, Yu MH, Ku CH, Chen CH, Wu GJ, Liu JY.
    BJOG; 2006 Jan; 113(1):47-52. PubMed ID: 16398771
    [Abstract] [Full Text] [Related]

  • 19. A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery.
    Ragab A, Barakat R, Alsammani MA.
    Int J Gynaecol Obstet; 2016 Jan; 132(1):82-4. PubMed ID: 26522140
    [Abstract] [Full Text] [Related]

  • 20. [Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial].
    Fekih M, Jnifene A, Fathallah K, Ben Regaya L, Memmi A, Bouguizene S, Chaieb A, Bibi M, Khairi H.
    J Gynecol Obstet Biol Reprod (Paris); 2009 Nov; 38(7):588-93. PubMed ID: 19833454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.